DALLAS, July 7, 2015 /PRNewswire/ --
According to a new market research report The report
"Nuclear Medicine/Radiopharmaceuticals Market by
Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic
(Beta Emitters - I-131, Alpha Emitters, Brachytherapy -
Y-90), by Application (Oncology,
Thyroid, Cardiology) - Global Forecasts to 2020",
published by MarketsandMarkets, this report studies the global
Nuclear Medicine/Radiopharmaceuticals Market for the forecast
period of 2015 to 2020. This market is expected to reach
$6.96 Billion by 2020 from
$4.50 Billion in 2015, at a CAGR of
9.1% during the forecast period.
Browse 113 market data Tables and 55 Figures spread through 230
Pages and in-depth TOC on "Nuclear Medicine
Market"
http://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html
Early buyers will receive 10% customization on this
report.
The global Nuclear Medicine/Radiopharmaceuticals Market is
segmented on the basis of type, application, and region.
On the basis of type, the Nuclear Medicine/Radiopharmaceuticals
Market is categorized into diagnostics and therapeutics segments.
In 2014, the diagnostics segment accounted for the largest share of
the Nuclear Medicine/Radiopharmaceuticals Market owing to
widespread use of radiopharmaceutical isotopes in diagnostic
instruments like PET and SPECT. The diagnostics market is further
segmented into SPECT and PET segments. In 2014, the SPECT segment
accounted for the largest share of the nuclear
medicine/radiopharmaceuticals diagnostics market. On the other
hand, the therapeutics market is further segmented into beta
emitters, alpha emitters, and brachytherapy isotopes. In 2014, the
beta emitters segment accounted for the largest share of the
nuclear medicine/radiopharmaceuticals therapeutics market. The year
2013 marked the advent of alpha emitters, which is likely to drive
the growth of the therapeutics market.
Inquiry before Buying:
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=417
On the basis of applications, the Nuclear
Medicine/Radiopharmaceuticals Market is segmented into diagnostics
(SPECT and PET) and therapeutics applications. In 2014, the
cardiology segment accounted for the largest share of the SPECT
markets; whereas, the oncology segment accounted for the largest
share of the PET market. On the other hand, the thyroid segment
accounted for the largest share of the therapeutics market.
On the basis of regions, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW:
Latin America, the Middle East, and Africa). In 2014, North America accounted for the largest share
of the Nuclear Medicine/Radiopharmaceuticals Market, followed by
Asia-Pacific and Europe.
Factors driving the Nuclear Medicine/Radiopharmaceuticals Market
include the increasing use of SPECT and PET scans results, advances
in radiotracers, alpha radio immunotherapy-based targeted cancer
treatment, and increasing incidences of cancer and cardiac ailments
which boost the demand for radiopharmaceuticals. However, factors
such as shorter half-life of radiopharmaceuticals, stringent
regulatory guidelines, and competition from conventional diagnostic
procedures are hindering the growth of this market.
Some of the major players in the Nuclear Medicine Market
include Cardinal Health, Inc. (U.S.), GE Healthcare (U.K.), Bracco
Imaging S.p.A (Italy),
Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications
S.A. (France), Bayer Healthcare
(Germany), Lantheus Medical
Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), and Mallinckrodt plc (Ireland).
Browse Related Reports:
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals &
Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium,
F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)]
& (Deuterium, C-13) - Forecast to 2017.
http://www.marketsandmarkets.com/Market-Reports/asia-pacific-nuclear-medicine-radiopharmaceuticals-market-1140.html
North American Nuclear Medicine/Radiopharmaceuticals &
Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium,
F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)]
& (Deuterium, C-13) - Forecast to 2017.
http://www.marketsandmarkets.com/Market-Reports/north-american-nuclear-medicine-radiopharmaceuticals-market-1108.html
About MarketsandMarkets:
MarketsandMarkets is world's No. 2 firm in terms of annually
published premium market research reports. Serving 1700 global
fortune enterprises with more than 1200 premium studies in a year,
M&M is catering to multitude of clients across 8 different
industrial verticals. We specialize in consulting assignments and
business research across high growth markets, cutting edge
technologies and newer applications. Our 850 fulltime analyst and
SMEs at MarketsandMarkets are tracking global high growth markets
following the "Growth Engagement Model - GEM". The GEM aims at
proactive collaboration with the clients to identify new
opportunities, identify most important customers, write "Attack,
avoid and defend" strategies, identify sources of incremental
revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research
platform, "RT" connects over 200,000 markets and entire value
chains for deeper understanding of the unmet insights along with
market sizing and forecasts of niche markets. The new included
chapters on Methodology and Benchmarking presented with high
quality analytical infographics in our reports gives complete
visibility of how the numbers have been arrived and defend the
accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence
repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @
http://mnmblog.org/market-research/healthcare/pharmaceuticals
Connect with us on LinkedIn
@ http://www.linkedin.com/company/marketsandmarkets